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Abstract
The palatine tonsil is an uncommon site of oral canine neoplasia. For affected tonsils, squamous
cell carcinoma is themost frequent type of neoplasia, followed bymelanoma and lymphoma. Com-
puted tomography (CT) is increasingly used for investigation of canine oropharyngeal pathology;
however, limited information is available on the CT appearance of tonsillar neoplasms. Objectives
of this retrospective descriptive case series were to characterize the CT features of canine tonsil-
lar neoplasia and determine whether specific CT features differentiate nonneoplastic from neo-
plastic tonsils. Computed tomographic studies of 14 dogs diagnosedwith tonsillar neoplasia were
retrieved from two referral hospitals and reviewed by two observers. Diagnosis was based on his-
tology or cytology. Carcinoma was diagnosed in 11 dogs, melanoma in two and lymphoma in one
dog. Specific CT features of the tonsil and regional lymph nodes did not differentiate neoplastic
from nonneoplastic tonsillar diseases, but regional lymph node CT features were useful for diag-
nosis in some cases. Marked enlargement (width ≥ 18 mm, 12/18), heterogeneity (16/18), and
loss of the hypoattenuating hilus (18/18) of the medial retropharyngeal lymph node were com-
mon concomitant features of tonsillar neoplasia. Themedial retropharyngeal andmandibular lym-
phadenomegaly was ipsilateral to the neoplastic tonsil in 8/12 and 6/9 dogs, respectively. Five
dogs demonstrated little or no enlargement of the tonsil despite the associated metastatic lym-
phadenomegaly. Tonsillar neoplasia should therefore be considered as a differential diagnosis for
dogs with CT evidence of isolated medial retropharyngeal lymphadenomegaly (regardless of nor-
mally sized tonsils), or of any enlarged tonsil with no associated lymphadenomegaly.
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1 INTRODUCTION
The palatine tonsil is recessed within the tonsillar fossa and is an
uncommon site of oropharyngeal neoplasia in the dog.1–4 Carcinoma
is the most frequent tumor type and is associated with a guarded
prognosis.4–8 Varying values of prevalence of canine tonsillar squa-
mous cell carcinoma have been reported, most recently it has been
described to represent 9% of canine oral tumors.4–8 Oral examination
combined with tonsillar cytology or biopsy is often the initial step in
the diagnosis of tonsillar neoplasia in the dog, which in many cases is
sufficient for diagnosis without further imaging.4–6 For oncological
staging and treatment planning of tonsillar neoplasia, computed
tomography (CT) is increasingly being applied. In addition, CT is
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commonly utilized in the first line of investigation for a large number
of patients with suspected oropharyngeal or cranial neck masses of
unknown origin. Scarce information is available on the CT appearance
of palatine tonsillar neoplasia in the dog.
The pharyngeal walls contain a ring of lymphoreticular tissue act-
ing as an immunological barrier for the respiratory and alimentary
systems.1 Tonsils are aggregates of multiple lymph nodes surrounded
by a common capsule.1 The dog has small, diffuse, unpaired lingual
and pharyngeal tonsils and distinct, paired palatine tonsils.2 The pala-
tine tonsil (tonsilla palatina) has a fusiform protruding portion 25 mm
in length, 5 mm in width, and 4 mm thickness in the normal adult dog
located in the lateral oropharyngeal wall.2,3 There is a smaller deeper
portion that lies under themucosa forming the lateral wall of the fossa
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that is usually only formed in pathologic conditions.3 Tonsillar enlarge-
ment can occur as a normal immune reaction to infectious stimuli, or as
a primary or metastatic neoplasia.4,9,10
The objectives of this study were to describe CT features of pala-
tine tonsillar neoplasia in a group of dogs with confirmed disease and
to determinewhether specific CT features differentiate nonneoplastic
fromneoplastic tonsils.Wehypothesized thatCT characteristics of the
canine palatine tonsil and regional lymph nodes would allow differen-
tiation of neoplastic from nonneoplastic tonsillar diseases.
2 METHODS
The study design was a retrospective descriptive case series. Data
from dogs diagnosed with tonsillar neoplasia were retrieved from the
databases of the referral hospitals of the University of Edinburgh and
the University of Milan. Diagnosis was based on tonsillar biopsy, or if
not available, on fine-needle aspiration of the tonsil. Inclusion crite-
ria for participation in the study consisted of an available CT study
of diagnostic quality of the head and neck before and within 5 min
after manual intravenous contrast medium injection (740 milligrams
Iodine/kilogram) prior to biopsy or treatment, complete patient sig-
nalment data and cytological or histological diagnosis. Decisions for
study inclusion were made by a diagnostic imaging resident (F.T.). Age,
sex, clinical signs, cytological, and histological results of the tonsils
and metastatic lesions were unblindly recorded by the same observer.
Open or closed-mouth status during CT examination was noted.
All CT studies were randomized and reviewed by a board-certified
veterinary radiologist (T.S.) who was unaware of the clinical findings,
tumour type, and location. All assessments and measurements were
performed using dedicatedDICOMviewer software (OsiriX v5.8.5 64-
bit, Geneva, Switzerland). A window width of 200 Hounsfield units
(HU) and awindow level of 50HUwere used. Thoracic CT imageswere
reconstructedwith a high frequency algorithmandwere also reviewed
when available.
The tonsillar appearance (homogeneity, heterogeneity, enhance-
ment) beforeandafter intravenous contrastmedium injectionwasdoc-
umented. The largest linear dimension of each tonsil was measured in
a transverse plane on postcontrast images. The CT appearance of neo-
plastic tonsils was compared to the CT appearance of confirmed non-
neoplastic tonsils on histology. The largest width and appearance of
each medial retropharyngeal, mandibular, deep, and superficial lymph
nodes were also recorded. The attenuation pattern (homogeneous or
heterogeneous), presence of a postcontrast rim enhancement, and loss
of the hypoattenuating hilus were documented for each lymph node.
The size of the lymph nodes was qualitatively scored as normal or
abnormally enlarged. This assessment was based on nodal width and
asymmetry. Regions of interest were drawn on each tonsil, and each
mandibular and medial retropharyngeal lymph node before and after
intravenous contrast medium injection. Computed tomographic atten-
uation values in Hounsfield units and standard deviation of mean den-
sity were recorded.
Statistical analyses were performed by one author (F.T.) using a
commercial software (SPSS 20 software for Macintosh, SPSS Inc.). In
order to take into account the breed effect on tonsillar size, dogs
were categorized into small, medium, and large breed dogs. The differ-
ence in size between neoplastic tonsils and nonneoplastic tonsils was
assessed with a Mann–Whitney U test. The critical significance level
for statistical tests was set at 0.05.
3 RESULTS
3.1 Signalment and clinical findings
Fourteen dogs met the inclusion criteria: nine cases from the refer-
ral hospital of the University of Edinburgh over an 8-year period and
five cases from the referral hospital of the University of Milan over
a 4-year period. The median age for included dogs was 10.5 years
(N = 14, range: 6–14). Canine breeds included Collie cross (4/14),
Cavalier King Charles spaniel (1/14), springer spaniel (2/14), Labrador
(1/14), West Highland white terrier (1/14), Maltese (1/14), Schnauzer
(1/14), Czechoslovakian wolfdog (1/14), and cross breed dogs (2/14).
There were seven females (two entire and five neutered) and seven
males (two entire and five neutered). Dysphagia was the most com-
mon clinical sign reported (7/14). Lethargy (5/14) and hypersalivation
(5/14) were also common clinical features, with halitosis only reported
in two cases. Themedian duration of clinical signswas 4weeks (N=13,
range: 1–16). Twenty tonsilswere sampled, amongwhich17werediag-
nosed neoplastic (10 by histology and 7 by cytology). Three tonsils
were confirmed nonneoplastic on histology. Final diagnosis was estab-
lished within 1 week after CT examination. Nine tonsils were diag-
nosed with tonsillar squamous cell carcinoma on histology (Fig. 1). On
cytology, a squamous cell origin was suspected in four tonsils with car-
cinoma. Melanoma was found unilaterally in two tonsils (Fig. 2). Bilat-
eral tonsillar lymphoma was diagnosed in case 1 by fine-needle aspira-
tion (Fig. 3). A large cell lymphoma was suspected for this case but the
owner declined further investigations. Both tonsils were sampled in six
dogs and bilateral involvement confirmed in 50% of them (cases 1, 10,
12).
3.2 Computed tomography image acquisition
parameters
All CT examinationswere performed under general anesthesia with an
endotracheal tube in place except for one dog. Open-mouth CT exam-
ination was performed in seven dogs. Computed tomographic images
were acquired with multidetector CT units. A 4-slice CT unit (Univer-
sity of Edinburgh - Somatom Volume Zoom, Siemens, Germany) and
a 16-slice CT unit (University of Milan - GE BrightSpeed Elite, Gen-
eral Electric, Italy) were used. Scan settings included slice thickness
from 1.25 to 3 mm, collimator pitch between 0.8 and 1.5, X-ray tube
potential 120 kVp, tube current exposure time product 50 to 200mAs,
matrix 512× 512, reconstructed with a low frequency algorithm.
3.3 Computed tomographic findings
Computed tomographic and diagnostic findings for individual dogs
are provided in Appendix 1. Hyoid bone deviation due to tonsillar
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F IGURE 1 Postcontrast computed tomographic images of case 11, illustrating (A) minimal tonsillar enlargement due to bilateral carcinoma
(arrows) and (B) enlargement and heterogeneity of both medial retropharyngeal lymph nodes with absent hilus (arrows). Window width =
200HU, window level= 50HU
F IGURE 2 Postcontrast computed tomographic images of case 8, illustrating (A) right tonsillar enlargement due to melanoma associated with
soft palate invasion (arrow) and (B) normal right mandibular lymph node with hypoattenuating hilus (arrow). Window width = 200 HU, window
level= 50HU
enlargement was found in three dogs (cases 2, 3, and 5), and deviation
by the medial retropharyngeal lymph node was described in one dog
(case 13). Hyoid bone andmandibular periosteal reaction was noted in
one dog (case 3). A mineralized focus within the neoplastic tonsil was
found in cases 3 and 14. Invasion of surrounding organs such as the
parotid salivary gland and musculature of the neck by the metastatic
medial retropharyngeal lymph nodewas described in case 14. Invasion
of the soft palate by the neoplastic tonsil was reported in four dogs
(cases 3, 8, 10, and 14; Fig. 2).
Computed tomographic features of neoplastic tonsils and con-
firmed nonneoplastic tonsils are summarized in Table 1. The size of
neoplastic tonsils was significantly different from the size of nonneo-
plastic tonsils (Mann–Whitney U, Nneoplastic = 17, Nnonneoplastic = 3,
U= 199, P= 0.03). A power analysis was not performed for this result.
The median size of the confirmed neoplastic tonsils was quantitatively
higher than for the confirmed nonneoplastic tonsils. The tonsillar size
was considered small (≤10 mm) in three patients with tonsillar carci-
noma. A metastatic lymphadenomegaly was confirmed for these three
cases.When dogswere categorized according to their size, themedian
tonsillar sizewas10.6mm(N=4, range: 5.9–14.4) for small dogbreeds,
15.8mm(N=11, range: 9.7–37.2) formediumdogbreeds, and36.4mm
(N = 2, range: 33.8–39.1) for large dog breeds. The patient affected by
tonsillar lymphoma exhibited one of the largest tonsillar sizes of our
population. Nonneoplastic and neoplastic tonsils did not demonstrate
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F IGURE 3 Postcontrast computed tomographic images of case 1, illustrating (A) bilateral tonsillar enlargement due to lymphoma (arrows) and
(B) marked enlargement and heterogeneity of both medial retropharyngeal lymph nodes with absent hilus (arrows). Window width = 200 HU,
window level= 50HU
TABLE 1 Computed tomographic features of neoplastic and confirmed nonneoplastic tonsils
Neoplastic Tonsils (n= 17) Nonneoplastic Tonsils (n= 3)
Median tonsillar size (range) 15.8mm* (5.9–41.6) 9.7 mm* (5.7–11.5)
Median precontrast attenuation (range) 49HU (29–75) 53HU (53–58)
Median postcontrast attenuation (range) 89HU (53–165) 98HU (72–118)
*statistical significant difference.
mm, millimeters; HU, Hounsfield units.
any specific contrast enhancement pattern. Postcontrast rim enhance-
ment was reported in two tonsils with lymphoma, two tonsils with
melanoma, one affected by squamous cell carcinoma but also within
one hyperplastic tonsil.
Eighteen medial retropharyngeal lymph nodes were scored as
enlarged in 12 dogs (median width: 19.6 mm). Marked enlargement
was reported for 67% (12/18) of these lymph nodes (width superior
or equal to 18 mm). In 73% of dogs (8/11), the medial retropharyn-
geal lymphadenomegaly was ipsilateral to the confirmed neoplastic
tonsil. Six dogs had an enlarged mandibular lymph node ipsilateral to
the confirmed neoplasia (N = 9, range: 7–11 mm). Heterogeneity was
described for 69% of the enlarged lymph nodes (22/32) on postcon-
trast images (Figs. 1 and 3). This subjective finding of heterogeneity
was supported by an increased standard deviation of the attenuation
value measured within these lymph nodes on pre- and postcontrast
images (Table 2). Rim enhancement was reported in seven heteroge-
neous lymph nodes. All normally sized lymph nodes had a homoge-
neous appearance on CT after contrast injection. Among the 32 lymph
nodes reported as enlarged on CT, a loss of the hypoattenuating hilus
was reported in 29 of them. The same feature was described in three
lymph nodes scored as normal in size. Lymphadenopathy was absent
in two dogs with tonsillar squamous cell carcinoma. The mandibular
andmedial retropharyngeal lymphadenomegaly noted on CTwas con-
firmed as metastatic for 41% of the lymph nodes (9/32 on histology
and 4/32 on cytology). Eight of these 13 metastatic lymph nodes were
heterogeneous with hypoattenuating centers, and 10 had a loss of the
hypoattenuating hilus. Cases 2 and 9 had a mandibular lymph node of
normal size (contralateral and ipsilateral, respectively) that was con-
firmed nonmetastatic on histology.
Regarding the deep cervical lymph nodes, lymphadenomegaly was
reported in cases 1, 11, and 14 (3/12). These dogs also had bilat-
eral mandibular and medial retropharyngeal lymphadenomegaly. All
24 superficial cervical lymph nodes identified on CT in the same 12
dogs were considered within normal limits on CT.
3.4 Other findings and treatment
Thoracic CT was performed in 13 dogs (Appendix 1). A single
dog demonstrated numerous pulmonary metastases up to 5 mm
(case 10). In this case, concomitant bilateral thyroid carcinoma was
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TABLE 2 Computed tomographic appearance of medial retropharyngeal and mandibular lymph nodes associated with tonsillar neoplasm in
14 dogs
Median Minimum Maximum
Precontrast attenuation of normal sized lymph node (n= 24) 41HU (SD 6.5) 17HU (SD 2) 79 (SD 15)
Postcontrast attenuation of normal sized lymph node (n= 24) 81HU (SD 8) 38HU (SD 3) 136HU (SD 21)
Precontrast attenuation of enlarged lymph node (n= 32) 36HU (SD 8) 18HU (SD 2) 57HU (SD 17)
Postcontrast attenuation of enlarged lymph node (n= 32) 92HU (SD 14) 41HU (SD 3) 126HU (SD 26)
HU, Hounsfield units; SD, standard deviation.
suspected as well on fine-needle aspiration. A 4 mm pulmonary nod-
ule was described in case 8. Its size remained static on follow-up CT
examination performed10months later,most consistentwith a benign
lesion. This dog diagnosed with right tonsillar melanoma also devel-
oped an aggressive neoplasia of the right mandible at that time. The
owner declined sampling of this new lesion however based on the clin-
ical history and imaging features, a primary tonsillar melanoma with a
metastaticmandibular lesionwas suspected. A large primarymandibu-
lar tumour was histologically diagnosed asmelanoma in case 5.
4 DISCUSSION
This is the first published study exclusively focusing on the tomo-
graphic features of tonsillar neoplasia in dogs. Carcinoma was the
most common neoplasm affecting the tonsil (79% of dogs) in our case
series, which is consistent with previous publications.7,8,11 Squamous
cell carcinoma was histologically confirmed in most of these animals.
Melanoma was the second most common malignancy (14%) and lym-
phoma was found in only one dog. It was interesting to note that,
despite the greater risk for tonsillar neoplasia reported for male ver-
sus female dogs, in our study there was a similar proportion of female
and male dogs.4–6,11 This could be due to selection bias, or related to
the neutered status ofmost of the dogs in our study. In humans, several
risk factors for tonsillar squamous cell carcinoma have been reported
such as tobacco, alcohol consumption and, to a lesser extent, human
papilloma virus.12
Interestingly, bilateral tonsillar neoplasia was reported in one dog
with lymphoma and two dogs with carcinoma. We hypothesized that
the largest tonsil may have represented the primary neoplasia that
has metastasized to the contralateral tonsil. The most enlarged lymph
node was always ipsilateral to the most enlarged tonsil in our pop-
ulation, which supported the same theory. A concomitant neoplastic
occurrence in both tonsils is another possibility. The likelihood of bilat-
eral neoplastic involvement was higher than in a previous study that
reported bilateral tonsillar squamous cell carcinoma in 33% of nine
cases.4 The high prevalence of 50% in our study may have been due
to the small sample size or the biased sampling of enlarged tonsils only.
Compression of surrounding soft tissue by the enlarged tonsil or lymph
node was a common finding in 43% of the dogs. Vascular invasion and
bone lysiswere not common features of tonsillar neoplasia in our study
although periosteal reaction was noted in one case of squamous cell
carcinoma. The soft palate was the most common site of invasion by
tonsillar neoplasms (29%). Such invasion is considered as an advanced
stage of tumour growth in dogs.4,5,13
The enhancement pattern of tonsils on CT was not specific to
a particular type of neoplasia. As expected, neoplastic tonsils were
generally enlarged compared to nonneoplastic tonsils. It should nev-
ertheless be noted that the size of the neoplastic tonsil remained nor-
mal or minimally enlarged in three dogs affected by neoplasia. A ton-
sillar neoplasm can therefore easily be missed when the size of the
tonsil remains small. To the author's knowledge, this feature has not
been emphasized in the veterinary literature and diagnosis of these
cases can be challenging.
The generalizedmandibular andmedial retropharyngeal lymphade-
nomegaly did not aid in differentiating between tumour types. In our
study, 86% of patients exhibited enlargement of at least one medial
retropharyngeal lymph node on CT. Mandibular lymphadenomegaly
(64% of patients) was always described in association with medial
retropharyngeal lymphadenomegaly. Among our included cases, there
was no enlarged lymph node reported to have a width between 12
and 18 mm. Therefore, authors decided to consider 18 mm as a cut-
off value abovewhich node enlargementwas consideredmarked.Most
dogs with tonsillar neoplasia (64%) presented with a medial retropha-
ryngeal lymphadenopathy superior or equal to 18 mm. Indeed medial
retropharyngeal lymph nodes are close to the tonsils and are consid-
ered sentinel lymphnodes.3 In accordancewith a recent publication on
nontonsillar malignancies of the head, the authors hence recommend
bilateral systematic samplingor removal of themedial retropharyngeal
lymph node in view of histology, in addition to the mandibular lymph
nodes, when a tonsillar neoplasm is suspected.14 In our study, 25% of
dogs also presented with a deep cervical lymphadenomegaly, which
was always seen in conjunction with a bilateral mandibular and medial
retropharyngeal lymphadenomegaly. In view of a complete staging,
we advise sampling of the deep cervical lymph nodes as well. A pre-
vious study on CT characteristics of pharyngeal neoplasia included
eight dogs with tonsillar carcinoma but specific features of tonsillar
neoplasia were not highlighted due to a merged description of multi-
ple pharyngeal neoplasms.11 Findings from this study were consistent
with some of our findings and demonstrated that medial retropharyn-
geal lymph nodes were more frequently affected than the mandibu-
lar nodes and that markedly enlarged, rounded, and heterogeneous
lymphnodeswere associatedwith a75%chanceof nodalmetastasis.11
With canine tonsillar squamous cell carcinoma, it has been demon-
strated that tumour size and nodal involvement are associated with
survival time.4 Tonsillar neoplasms can however coexist with normal
size lymph nodes as well (cases 4 and 7). The percentage of normal
appearing lymph nodes on CT that was confirmedmetastatic on cytol-
ogy was estimated at 6% (5/82) in a previous study.15 The differential
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diagnosis for tonsillar enlargement without associated lymphade-
nomegaly also includes several benign pathologies. Tonsillar lesions
such as lymphangiomatous polyp and epithelial cyst have been
reported.16,17 A study gathering eight dogs with tonsillar polyps,
mostly found incidentally, did not describe any lymphadenomegaly.17
The CT features of medial retropharyngeal lymph nodes do have bear-
ing in the radiological differential diagnosis. Neoplasia should remain
in the differential diagnosis of enlarged tonsils with no associated lym-
phadenomegaly on CT, alongside with tonsillar polyp, hyperplasia, or
tonsillitis.
Loss of the nodal hypoattenuating hilus was commonly reported in
91% of the enlarged lymph nodes in our study. Among the 13 con-
firmed metastatic lymph nodes, 77% of them presented this feature.
With nodal metastasis, the absence of the hilus on CT is thought to be
secondary to metastatic remodeling.18 As previously described in cats
with nasal neoplasia, loss of thehypoattenuating hiluswithin the lymph
node should be taken into account in the staging process of tonsillar
neoplasia on CT.18 However, this feature may also be considered in a
small number of cases as a normal node variant. Magnetic resonance
imaging is another modality that can bring additional information in
differentiating between neoplastic and inflammatory lymph nodes.19
Similar imaging features such as loss of the nodal hilus or heterogene-
ity are expected in metastatic lymph nodes due to tonsillar neoplasia.
In our study, another common concomitant imaging feature of tonsil-
lar neoplasia was nodal heterogeneity. A large number of confirmed
metastatic lymph nodes (61%) were heterogeneous with hypoatten-
uating centers on postcontrast images. Such an appearance was com-
patible with nodal necrosis. The authors would like to point out that
tonsillar neoplasia should be considered in the differential diagnosis
when an isolated medial retropharyngeal lymphadenomegaly is noted
on computed tomography, regardless of a normally sized tonsil. For
these cases, sampling of both tonsils should be advised to the clinician.
Pulmonary metastases at time of diagnosis were only described in
one case. Distant metastasis was not a common feature of tonsillar
neoplasia in our population. The same finding was described in a ret-
rospective study, in which none of the 33 dogs with tonsillar squa-
mous cell carcinoma had lung metastasis on radiography at the time of
diagnosis.6 An older study reported a higher rate of lung metastases
on postmortem examination in 21% of 24 dogs with tonsillar squa-
mous cell carcinoma.20 Later stage cancer may explain the differing
prevalence for distant lung metastasis. In case 5, the large mandibular
melanoma likely represented a primary neoplasia that metastasized to
the tonsil. The palatine tonsil does not have any afferent lymphatics so
anymetastasis in a tonsil originates fromhematogenous spread, hence
implying apoorprognosis.3,21 In thehuman literature, only0.8%of ton-
sillar malignancies result from metastasis of nonhematological malig-
nant neoplasm.9 Bilateral thyroid gland invasionwas suspected in case
10.On computed tomography, both tonsilswere relatively small, which
precludes us from hypothesising on the nature of the primary neopla-
sia for this case. These cases highlight the aggressive local metastatic
potential of tonsillar neoplasia.
With respect to limitations of this study, the small sample size pre-
cluded us from performing meaningful statistics beyond the included
tests. Due to the retrospective nature of the case series, histology
was not performed on all enlarged lymph nodes noted on CT. Patients
had variable delays up to 5 min between the injection of contrast
mediumand theCTacquisitionwhichmay explain thewide variation of
tonsillar enhancement on postcontrast images and lack of differenti-
ation between neoplastic and nonneoplastic tonsils. This lack of dif-
ferentiation may also be explained by the different concentrations of
contrast medium products that have been used. The palatine tonsil is
a small organ that can be challenging to delineate on CT. The use of
open-mouth CT examination has been recommended to identify the
pharyngeal structures.22 Open-mouth CT was performed in 50% of
the examinations included in our study. In the author's experience, it
greatly improved the visualization of the tonsils. Closed-mouth exami-
nationmay have causedmild inaccuracy of the tonsillarmeasurements
in seven cases. The small number of confirmed nonneoplastic tonsils is
a limitation to the comparison between neoplastic and nonneoplastic
tonsils in our study. The size of the two tonsils diagnosed as hyperplas-
tic may have been slightly increased. This limitation is related to the
lack of information in the literature on the tomographic appearance of
normal canine tonsils.
In conclusion, our primary hypothesis that CT characteristics of
the canine palatine tonsil and regional lymph nodes would differenti-
ate neoplastic from nonneoplastic tonsils was rejected. However, the
lymph node appearancewas helpful in distinguishing neoplastic versus
nonneoplastic disease for some cases. Marked enlargement (≥18 mm
width on transverse CT images), heterogeneity, and loss of the hypoat-
tenuating hilus of medial retropharyngeal lymph nodes were common
concomitant features of tonsillar neoplasia on postcontrast CT images.
Although these nodal features were not seen in all patients with ton-
sillar neoplasia, they represented a useful tool in the diagnostic pro-
cess and differentiation between neoplastic and nonneoplastic ton-
sils for patients in which they were present. Tonsillar neoplasia should
therefore be considered in the differential diagnosis list for dogs with
CT features of tonsillar enlargement with or without regional lymph
node enlargement, or isolatedmedial retropharyngeal lymphadenopa-
thy with or without tonsillar enlargement.
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